Monitoring enzyme replacement therapy in Fabry disease—Role of urine globotriaosylceramide

Author: Whitfield P.   Calvin J.   Hogg S.   O’Driscoll E.   Halsall D.   Burling K.   Maguire G.   Wright N.   Cox T.   Meikle P.   Deegan P.  

Publisher: Springer Publishing Company

ISSN: 0141-8955

Source: Journal of Inherited Metabolic Disease, Vol.28, Iss.1, 2005-01, pp. : 21-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content